What are the key clinical features and laboratory findings that suggest a diagnosis of Goodpasture's syndrome in a patient presenting with pulmonary-r

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 22 August 2025Updated: 22 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

Key clinical features of Goodpasture's syndrome in a patient presenting with pulmonary-renal syndrome include rapidly progressive glomerulonephritis manifesting as haematuria, proteinuria, and acute kidney injury, alongside pulmonary symptoms such as haemoptysis, dyspnoea, and cough due to pulmonary haemorrhage. Constitutional symptoms like fatigue and malaise may also be present. The combination of these pulmonary and renal manifestations is characteristic of the syndrome .

Laboratory findings that suggest Goodpasture's syndrome include the presence of circulating anti-glomerular basement membrane (anti-GBM) antibodies detected by ELISA or immunofluorescence, which are highly specific for the disease . Urinalysis typically shows active sediment with red blood cell casts and proteinuria. Renal biopsy reveals crescentic glomerulonephritis with linear IgG deposition along the glomerular basement membrane on immunofluorescence, confirming the diagnosis . Pulmonary imaging may show diffuse alveolar infiltrates consistent with pulmonary haemorrhage.

In summary, the diagnosis of Goodpasture's syndrome in pulmonary-renal syndrome is suggested by the clinical triad of rapidly progressive glomerulonephritis, pulmonary haemorrhage, and detection of anti-GBM antibodies, supported by characteristic renal biopsy findings .

Educational content only. Always verify information and use clinical judgement.